Addex Therapeutics LTD ADDEX THER.../ CH0029850754 /
- - | Chg. - | Volume | Bid06:00:09 | Ask06:00:09 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-CHF | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 10.37 mill.CHF | - | - |
GlobeNewswire
06/06
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
GlobeNewswire
31/05
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
18/04
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
11/04
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18,...
GlobeNewswire
03/04
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Mod...
GlobeNewswire
31/01
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire
23/11/2023
Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...
GlobeNewswire
06/09/2023
Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference